Imprecision of counting CFU-GM colonies and CD34-expressing cells

Bone Marrow Transplantation

Volumn 20, Issue 1, 1997, Pages 57-61

  Serke, S ^a   Arseniev, L ^b   Watts, M ^c   Fritsch, G ^d   Ingles Esteve, J ^e   Johnsen, H E ^f   Linch, D ^c   Cancelas, J A ^e   Meyer, O ^a   Kadar, J G ^b   Huhn, D ^a   Matcham, J ^g  

^a HUMBOLDT UNIVERSITY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d ST ANNA CHILDREN S HOSPITAL   (Austria)

^e HOSPITAL DURAN I REYNALS   (Spain)

^f GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^g AMGEN LTD   (United Kingdom)

Author keywords

CD34 cells; CFU GM; Imprecision; Laboratory assessment

Indexed keywords

CD34 ANTIGEN;

ACCURACY; ARTICLE; COLONY FORMING UNIT GM; CONTROLLED STUDY; CYTAPHERESIS; DATA ANALYSIS; FLOW CYTOMETRY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; PRIORITY JOURNAL; STEM CELL; TREATMENT OUTCOME;

EID: 0030764484     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700830     Document Type: Article

References (23)

1. Siena S, Bregni M, Brando B et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991; 77: 400-409.
2. + cells: correlation to the quantitation of circulating haemopoietic progenitor cells by in vitro colony assay. Br J Haematol 1991; 77: 453-459.
3. Fruehauf S, Haas R, Conradt C et al. Peripheral blood progenitor cell (PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (R-metHuG-CSF)-supported cytotoxic chemotherapy. Blood 1995; 85: 2619-2626.
4. Orlic D, Bodine DM. What defines a pluripotent hematopoietic stem cell (PHSC): will the real PHSC please stand up! Blood 1994; 84: 3991-3994.
5. Berardi AC, Wang A, Levine JD et al. Functional isolation and characterization of human hematopoietic stem cells. Science 1995; 267: 104-107.
6. Spitzer G, Verma DS, Fisher R et al. The myeloid progenitor cell - its value in predicting haemopoietic recovery after autologous transplantation. Blood 1980; 55: 317-323.
7. Messner HA, Curtis JE, Minden MD et al. Clonogenic hemopoietic precursors in bone marrow transplantation. Blood 1987; 70: 1425-1432.
8. To LB, Dyson PG, Juttner CA. Cell dose effect in circulating stem cell autografting. Lancet 1986; ii: 404.
9. Bensinger WI, Longin K, Appelbaum F et al. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony-stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 1994; 87: 825-831.
10. Kreissig C, Kirsch A, Serke S. Characterization and measurement of CD34-expressing hematopoietic cells. J Hematother 1994; 3: 263-290.
11. Richman CM, Weiner RS, Yankee RA. Increase in circulating stem cells following chemotherapy in man. Blood 1976; 47: 1031-1039.
12. Coulombel L, Eaves AC, Eaves CJ. Enzymatic treatment of long-term human marrow cultures reveals the preferential location of primitive hemopoietic progenitors in the adherent layer. Blood 1983; 62: 291-297.
13. Keating A, Powell J, Takahashi M, Singer JW. The generation of human long-term marrow cultures from marrow depleted of Ia (HLA-DR) positive cells. Blood 1984; 64: 1159-1162.
14. + cells. Blood 1996; 87: 949-955.
15. Bühring HJ, Asenbauer B, Katrilaka K et al. Sequential expression of CD34 and CD33 antigens on myeloid colony-forming cells. Eur J Haematol 1989; 42: 143-149.
16. Caracciolo D, Clark S, Rovera G. Differential activity of recombinant colony-stimulating factors in supporting proliferation of human peripheral blood and bone marrow myeloid progenitors in culture. Br J Haematol 1989; 72: 306-311.
17. Juttner CA, Fibbe WE, Nemunaitis J et al. Blood cell transplantation: report from an international consensus meeting. Bone Marrow Transplant 1994; 14: 689-693.
18. To LB, Roberts MM, Rawling C et al. Establishment of a clinical threshold cell dose: correlation between CFU-GM and duration of aplasia. In: Wunder E, Sovalat H, Henon PR, Serke S (eds). Hematopoietic Stem Cells. AlphaMed Press: Dayton, 1994, pp 15-20.
19. Schwella N, Beyer J, Schwaner I et al. Impact of preleukapheresis cell counts on collection results and correlation of progenitor cell dose with engraftment after high-dose chemotherapy in patients with germ cell cancer. J Clin Oncol 1996; 14: 1114-1121.
20. + cells predict a rapid platelet recovery after peripheral blood stem cell transplantation. Blood 1995; 85: 3313-3319.
21. Bensinger W, Appelbaum F, Rowley S et al. Factors that influence collection and engraftment of autologous peripheral blood stem cells. J Clin Oncol 1995; 13: 2547-2555.
22. Schwella N, Siegert W, Beyer J et al. Autografting with blood progenitor cells: predictive value of preapheresis blood cell counts on progenitor cell harvest and correlation of the reinfused cell dose with haematopoietic reconstitution. Ann Haematol 1995; 71: 227-234.
23. Watts MJ, Sullivan AM, Jamieson E et al. Progenitor cell mobilisation after low dose cyclophosphamide and G-CSF: an analysis of progenitor cell quantity and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma. J Clin Oncol 1996 (in press).